Galectin-2 antibody
Principal name
Galectin-2 antibody
Alternative names for Galectin-2 antibody
LGALS2, Lactose-binding lectin 2, S-Lac lectin 2, HL14, Beta-galactoside-binding lectin L-14-II
Ncbi ID
NP_006489.1, NP_006489, NP_079898.2, AAH59782.1, NM_006498, NP_079898, NM_025622, NM_133599
Available reactivities
Available hosts
Available applications
Frozen Sections (C), Enzyme Immunoassay (E), Immunoprecipitation (IP), Western blot / Immunoblot (WB), Immunocytochemistry/Immunofluorescence (ICC/IF), Paraffin Sections (P)
Background of Galectin-2 antibody
- Kit Component:
- - KN309242G1, Lgals2 gRNA vector 1 in pCas-Guide vector
- KN309242G2, Lgals2 gRNA vector 2 in pCas-Guide vector
- KN309242D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Loser K., et al. (2009) J Immunol. 182(9):5419-29.
Ozaki K., et al. (2009) Nat Genet. 41(3):329-33.
The figure shows SDS-PAGE and WESTERN BLOTTING: (a) SDS-Page of crude extract of Suberites domuncula (b) Size-separated proteins were transferred to membranes and reacted with antibody. (M) Molecular mass marker proteins
Immunofluorescence of Galectin-2 staining in resin sections of S. domuncula tissue. The section was incubated with AP02095SU followed by Goat anti-Rabbit antibody coupled to Cy3. (C) AP02095SU stains the surface and the axial canal/axial filaments of the spicules. (D) corresponding Nomarsky interference image. sp, spicules. Schroder HC et al. (2006) J Biol Chem 281(17): 12001-12009.
Western blot analysis of LGALS2 Antibody (Center) (AP18097PU-N) in mouse stomach tissue lysates (35ug/lane). LGALS2 (arrow) was detected using the purified Pab.
Recombinant human LGALS2, 1-132 aa, His-tagged
Representative Standard Curve
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY LGALS2 (RC209552, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-LGALS2.
Immunohistochemistry analysis of paraffin-embedded human heart tissue using LEG2 antibody.The picture on the right is treated with the synthesized peptide.
Immunofluorescence analysis of COS-7 cells, using LEG2 antibody.The picture on the right is treated with the synthesized peptide.
Gel: 12%SDS-PAGE, Lysate: 40 µg, Lane: Mouse small intestines tissue, Primary antibody: LGALS2 Antibody at dilution 1/300, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 5 minutes
The image on the left is immunohistochemistry of paraffin-embedded Human ovarian cancer tissue using LGALS2 Antibody at dilution 1/30, on the right is treated with fusion protein. (Original magnification: ×200)
The image on the left is immunohistochemistry of paraffin-embedded Human ovarian cancer tissue using LGALS2 Antibody at dilution 1/30, on the right is treated with fusion protein. (Original magnification: ×200)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA314151 | Galectin-2 antibody |
||||||
| Rabbit polyclonal anti-LEG2 antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms | E, ICC/IF, P |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
 +1 additional image |
|||||||
| TA322490 | Galectin-2 antibody |
||||||
| Anti-LGALS2 Rabbit Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| +2 additional images |
|||||||
| TA803291 | Galectin-2 antibody |
||||||
| LGALS2 mouse monoclonal antibody, clone OTI6A8 (formerly 6A8) | |||||||
 |
Mouse | IgG1 | OTI6A8 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| AP02095SU-N | Galectin-2 antibody |
||||||
 |
Rabbit | Serum | C, E, IP, WB |
0.1 ml /
€500.00
|
|||
| OriGene Technologies GmbH | |||||||
| +1 additional image |
|||||||
| AP02095SU-S | Galectin-2 antibody |
||||||
|
Rabbit | Serum | C, E, IP, WB |
20 µl /
€170.00
|
|||
| OriGene Technologies GmbH | |||||||
| +1 additional image |
|||||||
| AP18097PU-N | Galectin-2 antibody |
||||||
 |
Rabbit | Hu, Ms | WB |
0.4 ml /
€415.00
|
|||
| OriGene Technologies GmbH | |||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP309552 | Galectin-2 |
||||
| Recombinant protein of human lectin, galactoside-binding, soluble, 2 (LGALS2) | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| PR27161-5 | Galectin-2 |
||||
 |
Human | Purified | > 95 % | E. coli |
5 µg /
€190.00
|
| Neuromics Antibodies | |||||
| PR27161-25 | Galectin-2 |
||||
|
Human | Purified | > 95 % | E. coli |
25 µg /
€290.00
|
| Neuromics Antibodies | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY416599 | LGALS2 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR200739L2V | Lenti ORF particles, Lgals2 (GFP-tagged) - Mouse lectin, galactose-binding, soluble 2 (Lgals2), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR200739L1V | Lenti ORF particles, Lgals2 (Myc-DDK-tagged) - Mouse lectin, galactose-binding, soluble 2 (Lgals2), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR204130L2V | Lenti ORF particles, Lgals2 (GFP-tagged ORF) - Rat lectin, galactoside-binding, soluble 2 (Lgals2), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| RR204130L1V | Lenti ORF particles, Lgals2 (Myc-DDK-tagged ORF) - Rat lectin, galactoside-binding, soluble 2 (Lgals2), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
